Literature DB >> 24781504

Identification of risk and prognostic factors for patients with clonorchiasis-associated intrahepatic cholangiocarcinoma.

Guo-Wei Zhang1, Jian-Hua Lin, Jian-Ping Qian, Jie Zhou.   

Abstract

BACKGROUND: Intrahepatic cholangiocarcinoma caused by clonorchiasis (CICC) has a poor prognosis, and there have been insufficient studies regarding risk and prognostic factors. We aimed to identify CICC-associated factors.
METHODS: A retrospective analysis of 127 eligible patients with CICC was performed with 254 clonorchiasis cases used as matched controls to identify risk factors for CICC. The main outcomes analyzed included overall survival (OS) and disease-free survival (DFS).
RESULTS: Out of 127 surgeries, R0 resection was performed in 61 patients, R1 in 32 patients, and R2 in 22 patients; nonresection surgery was performed in 12 patients. Median OS for the entire cohort was 29.5 months. Median OS and DFS for 61 patients with R0 resection were 52.4 months and 41.5 months, respectively. We found independent risk factors for CICC were duration of raw fish consumption of ≥28 years (p < 0.001) and hepatitis B virus infection (p = 0.040). R0 resection (p < 0.001), well or moderately differentiated tumor (p = 0.019), and stage I to II tumor (p < 0.001) predicted improved OS for CICC. Serum carcinoembryonic antigen level of ≤5 ng/ml (p = 0.029) and stage I to II tumor (p < 0.001) predicted improved DFS.
CONCLUSIONS: Duration of raw fish consumption ≥28 years and hepatitis B virus infection were significant risk factors for CICC in patients with clonorchiasis. For patients with CICC, curative resection is an effective treatment. Higher tumor differentiation and earlier American Joint Committee on Cancer stage predicted good prognosis. Serum carcinoembryonic antigen level was found to predict the possibility of recurrence after curative resection.

Entities:  

Mesh:

Year:  2014        PMID: 24781504     DOI: 10.1245/s10434-014-3710-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  13 in total

Review 1.  Hepatitis B virus and hepatitis C virus play different prognostic roles in intrahepatic cholangiocarcinoma: A meta-analysis.

Authors:  Zheng Wang; Yuan-Yuan Sheng; Qiong-Zhu Dong; Lun-Xiu Qin
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

Review 2.  Hepatolithiasis and intrahepatic cholangiocarcinoma: A review.

Authors:  Hyo Jung Kim; Jae Seon Kim; Moon Kyung Joo; Beom Jae Lee; Ji Hoon Kim; Jong Eun Yeon; Jong-Jae Park; Kwan Soo Byun; Young-Tae Bak
Journal:  World J Gastroenterol       Date:  2015-12-28       Impact factor: 5.742

3.  MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN.

Authors:  Li-Juan Wang; Chen-Chen He; Xin Sui; Meng-Jiao Cai; Cong-Ya Zhou; Jin-Lu Ma; Lei Wu; Hao Wang; Su-Xia Han; Qing Zhu
Journal:  Oncotarget       Date:  2015-03-20

4.  Establishment of a patient-derived intrahepatic cholangiocarcinoma xenograft model with KRAS mutation.

Authors:  Giuliana Cavalloni; Caterina Peraldo-Neia; Francesco Sassi; Giovanna Chiorino; Ivana Sarotto; Massimo Aglietta; Francesco Leone
Journal:  BMC Cancer       Date:  2016-02-11       Impact factor: 4.430

5.  Systematic review and meta-analysis: cholecystectomy and the risk of cholangiocarcinoma.

Authors:  Jianping Xiong; Yaqin Wang; Hanchun Huang; Jin Bian; Anqiang Wang; Junyu Long; Ying Zheng; Xinting Sang; Yiyao Xu; Xin Lu; Haitao Zhao
Journal:  Oncotarget       Date:  2017-07-26

6.  Overexpression of the X-linked ribosomal protein S4 predicts poor prognosis in patients with intrahepatic cholangiocarcinoma.

Authors:  Jie Kuang; Qin-Yu Li; Fei Fan; Ning-Jia Shen; Yong-Jie Zhan; Zhao-Hui Tang; Wen-Long Yu
Journal:  Oncol Lett       Date:  2017-05-08       Impact factor: 2.967

Review 7.  Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Authors:  Seogsong Jeong; Ying Tong; Meng Sha; Jinyang Gu; Qiang Xia
Journal:  Oncotarget       Date:  2017-03-07

8.  Heat shock proteins 70 and 90 from Clonorchis sinensis induce Th1 response and stimulate antibody production.

Authors:  Eun Joo Chung; Young-Il Jeong; Myoung-Ro Lee; Yu Jung Kim; Sang-Eun Lee; Shin-Hyeong Cho; Won-Ja Lee; Mi-Yeoun Park; Jung-Won Ju
Journal:  Parasit Vectors       Date:  2017-03-01       Impact factor: 3.876

9.  Increased hepatic Th2 and Treg subsets are associated with biliary fibrosis in different strains of mice caused by Clonorchis sinensis.

Authors:  Bei-Bei Zhang; Chao Yan; Fan Fang; Ying Du; Rui Ma; Xiang-Yang Li; Qian Yu; Di Meng; Ren-Xian Tang; Kui-Yang Zheng
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

10.  Natural History and Prognostic Factors of Cholangiocarcinoma With Spinal Metastasis: A 10-Year Single Center Study.

Authors:  Apiruk Sangsin; Dew Saiudom; Suthipas Pongmanee; Jirawat Saengsin; Taninnit Leerapun; Hideki Murakami
Journal:  Clin Spine Surg       Date:  2018-04       Impact factor: 1.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.